Nasdaq biib.

MEDIA CONTACTS: Biogen Jack Cox + 1 210 544 7920 [email protected] Alcyone Therapeutics Aurora Krause + 1 978-709-1946 [email protected]: INVESTOR CONTACTS:NASDAQ: BIIB · IEX Real-Time Price · USD Watchlist Buy BIIB on Public 232.06 +4.65 (2.04%) At close: Nov 29, 2023, 4:00 PM 233.00 +0.94 (0.41%) Pre …Average Age. Experienced Board: BIIB's board of directors are considered experienced (4.4 years average tenure). Ownership. Learn about Biogen Inc. (BIIB) stock's management team. Comprehensive performance, salary and tenure analysis for the CEO, board and leadership team.Previous Close $237.21. Volume 681.40K. Average Volume (3M) 872.44K. Market Cap. $34.35B. Enterprise Value $34.86B. Total Cash (Recent Filing) $6.08B. Total Debt (Recent Filing) $6.59B. Price to Earnings (P/E) 12.9.

Biogen Inc. (NASDAQ:BIIB) posted its quarterly earnings results on Wednesday, November, 8th. The biotechnology company reported $4.36 EPS for the quarter, beating analysts' consensus estimates of $3.99 by $0.37. The biotechnology company had revenue of $2.53 billion for the quarter, compared to analysts' expectations of $2.40 billion.May 27, 2021 · Nasdaq Composite Stock Market Premium Services. Stock Advisor. Our Flagship Service. Return. 525%. S&P Return. ... (BIIB-0.60%) stock has taken investors on the ride of a lifetime. Shares have ...

Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. $88.70 +1.21 +1.38%. Plug Power, Inc. Common Stock. $9.46 -1.29. Biogen Inc ...

NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...BIIB: Biogen Inc - Stock Price, Quote and News - CNBC138.99M. -77.03%. Get the latest Biogen Inc (BIIB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …(NASDAQ: BIIB) Biogen's 52-week high was $319.76, and its 52-week low was $220.86. It is currently -26.62% from its 52-week high and 6.24% from its 52-week low.

CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing ACTEMRA. The TOFIDENCE intravenous formulation is approved for the …

Find the latest Institutional Holdings data for Biogen Inc. Common Stock (BIIB) at Nasdaq.com.

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the commencement of an offer to purchase for cash (the “Cash Offer”) any and all ...CAMBRIDGE, Mass. and BEIJING, July 12, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and InnoCare Pharma Limited (HKEX: 09969) today announced that they have entered into a license and ...Given the large stake in the stock by institutions, Biogen's stock price might be vulnerable to their trading decisions The top 15 shareholders own 51% of the company Recent sales by insidersCAMBRIDGE, Mass., March 14, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced new data and updates from its SPINRAZA ® (nusinersen) and spinal muscular atrophy (SMA) research ...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Biogen and Sage enter into an agreement to jointly develop and commercialize zuranolone and SAGE-324 in the U.S.; Biogen to receive exclusive license to develop and commercialize zuranolone and SAGE-324 outside of the U.S., excluding rights to zuranolone in Japan, Taiwan and South Korea; Sage Therapeutics to receive $1.525 …December 3, 2023. Polar Capital Holdings Plc lifted its position in Biogen Inc. ( NASDAQ:BIIB - Free Report) by 30.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 325,000 shares of the biotechnology company's stock after acquiring an additional 75,000 shares during the ...

He likes Eli Lilly and Co (NYSE:LLY) over Cassava Sciences and Biogen Inc. (NASDAQ:BIIB). Cramer said Root, Inc. (NASDAQ:ROOT) is a "not-so-great" insurance technology firm. He recommends selling ...Biogen (NASDAQ: BIIB) Biogen is a biotech company focused on developing therapies for neurological diseases and related therapeutic adjacencies. Biogen has been in the news due to its ill-fated ...The analyst raised some key concerns for the stock in his research report. Skorney expects BIIB to generate revenues of $2.54 billion versus Street estimates of $2.48 billion in Q2. The analyst ...Current Trading Halts. Nov 30, 2023. Halt times displayed are Eastern Time (ET). updating.... Pause Threshold Price. If a security is subject to a Trading Pause, the Pause Threshold Price field will contain the reference threshold price that deviates 10% from a print on the Consolidated Tape that is last sale eligible as compared to every print ...CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) is bringing its well-recognized Community Lab science learning program together with the Lemelson-MIT Program ...Biogen (NASDAQ: BIIB) stock has been one of the few drug stocks that have lit up the investment world recently. The approval by U.S. regulators of its novel Alzheimer’s drug Aduhelm sent its ...Biogen-Sage Therapeutics postpartum depression pill priced at $15,900. Biogen and Sage Therapeutics' oral pill to treat postpartum depression (PPD) in adults is expected to cost U.S. wholesalers $15,900 for a full 14-day treatment, Sage Therapeutics said on Tuesday. Other symbols:

Times have been harder since, as Ionis has earned revenues of $729m, $811m, and $587m in 2020, 2021 and 2022, respectively, and reported net income in those three years of $ (479.7m), $ (28.6m ...CAMBRIDGE, Mass., March 16, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that The Journal of Prevention of Alzheimer’s Disease (JPAD) today published a peer-reviewed manuscript ...

Oct 21, 2021 · Our data suggests that insiders own under 1% of Biogen Inc. in their own names. Being so large, we would not expect insiders to own a large proportion of the stock. Collectively, they own US$84m ... Biogen ( NASDAQ: BIIB) is a global biotechnology company that focuses on the development and commercialization of therapies for neurological and …CAMBRIDGE, Mass., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Today, Biogen Inc. (Nasdaq: BIIB) announced positive data from the 24-week systemic lupus erythematosus (SLE) portion of the Phase 2 LILAC study ...Biogen Inc. (BIIB) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 234.64 +0.56 (+0.24%) At close: 04:00PM EST 235.00 +0.36 (+0.15%) After …Jul 6, 2023 · Analyst Price Forecast Suggests 21.57% Upside. As of July 6, 2023, the average one-year price target for Biogen is 342.30. The forecasts range from a low of 265.63 to a high of $417.90. The ... Biogen Inc. (NASDAQ:BIIB) discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company is an ethics stock because Biogen Inc ...

Times have been harder since, as Ionis has earned revenues of $729m, $811m, and $587m in 2020, 2021 and 2022, respectively, and reported net income in those three years of $ (479.7m), $ (28.6m ...

BIIB: Biogen Inc - Stock Price, Quote and News - CNBC

As of April 24, 2023, the average one-year price target for Biogen is 330.56. The forecasts range from a low of 265.63 to a high of $407.40. The average price target represents an increase of 8.65 ...CAMBRIDGE, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced that the Committee for Medicinal Products for Human Use (CHMP) of ...CAMBRIDGE, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) reported new promising Phase 1b clinical data showing that the investigational antisense oligonucleotide (ASO) therapy, BIIB080, reduced soluble tau protein in cerebrospinal fluid (CSF) in a dose-dependent and sustained manner in …Find the latest dividend history for Biogen Inc. Common Stock (BIIB) at Nasdaq.com.CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the expiration date results of its previously announced offer to purchase for cash ...Biogen Inc. (NASDAQ:BIIB) Q3 2023 Earnings Call Transcript November 8, 2023 Biogen Inc. beats earnings expectations. Reported EPS is $4.36, expectations were $3.97. Operator: Good morning. My name ...Find the latest dividend history for Biogen Inc. Common Stock (BIIB) at Nasdaq.com. Feb 6, 2023 · Biogen's total debt was $6,634 million in Q3 2022, down 13.8% from the end of 2021. In July 2022, the company redeemed 3.625% senior notes ahead of maturity, decreasing the Total Debt/EBITDA ratio ... 06, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the appointment of Monish Patolawala, currently President and Chief Financial Officer of ...

Biogen (NASDAQ:BIIB) – Biogen is a biopharma company that discovers, develops, and delivers therapies for the treatment of neurological and neurodegenerative diseases. BIIB stock’s average ...BIIB (U.S.: Nasdaq) Overview News Biogen Inc. No significant news for in the past two years. Key Stock Data ( 12/01/23) Shares Sold Short 2.63 M Change from Last -2.28% Percent of Float 1.83%...Biogen (NASDAQ: BIIB) Biogen is a biotech company focused on developing therapies for neurological diseases and related therapeutic adjacencies. Biogen has been in the news due to its ill-fated ...According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...Instagram:https://instagram. spy chartsbest future trading platformliberty silver dollar value 1921expi stock forecast The latest price target for . Biogen (NASDAQ: BIIB) was reported by Morgan Stanley on Friday, November 10, 2023.The analyst firm set a price target for 373.00 expecting BIIB to rise to within 12 ...CAMBRIDGE, Mass. and TOKYO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that, after consulting with the U.S. Food and Drug ... aarp dental insurance plan costhow much is a wsj subscription BIIB | Complete Biogen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.2,091.70 +34.50(+1.68%) Advertisement Biogen Inc. (BIIB) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 234.64 +0.56 (+0.24%) At close: … biol stock forecast CAMBRIDGE, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced several changes to its Board of Directors today. The changes will refresh the composition of the Board and ...What is Biogen Inc. (BIIB)'s stock price history? Over the last year, Biogen Inc.’s stock price has decreased by 25.02%. Biogen Inc. is currently approximately $227.41 per share.